Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of clinical outcomes associated with dosing metronidazole every 8 hours versus every 12 hours: a systematic review and metaanalysis.

Proceedings (Baylor University. Medical Center)·2024
Same author

Postpartum Invasive Group A Streptococcus Infection: Case Report and Mini-review.

Cureus·2018
Same author

Streptococcus Gordonii Empyema: A Case Report and Review of Empyema.

Cureus·2017
Same author

Education and Communication in an Interprofessional Antimicrobial Stewardship Program.

The Journal of the American Osteopathic Association·2016
Same author

Prevalence of off-label use of oral oncolytics at a community cancer center.

Journal of oncology practice·2015
Same author

Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit?

Journal of pharmacy practice·2014

Related Experiment Video

Updated: Jul 16, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Oxycodone accumulation in a hemodialysis patient.

Pamela A Foral1, Joseph R Ineck, Kelly K Nystrom

  • 1Alegent Health, Bergan Mercy Medical Center, and Creighton University, Omaha, NE, USA. pforal@creighton.edu

Southern Medical Journal
|March 3, 2007
PubMed
Summary

Oxycodone accumulation can cause serious adverse effects in patients with chronic kidney disease undergoing hemodialysis. Caution is advised when prescribing oxycodone to patients with renal impairment.

Related Experiment Videos

Last Updated: Jul 16, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

  • Pharmacology
  • Nephrology
  • Clinical Toxicology

Background:

  • Oxycodone is a widely used opioid analgesic for pain management.
  • Renal dysfunction can significantly alter the pharmacokinetics of oxycodone and its metabolites.
  • Accumulation of opioids in patients with impaired renal clearance poses a risk of toxicity.

Observation:

  • A case report details a 41-year-old patient on chronic hemodialysis who received oxycodone/acetaminophen.
  • The patient experienced lethargy, hypotension, and respiratory depression due to medication accumulation.
  • Naloxone administration, including a 45-hour continuous infusion, successfully reversed the adverse effects.

Findings:

  • The patient's symptoms were deemed a "probable" adverse drug reaction to oxycodone, assessed via the Naranjo scale.
  • This case highlights the prolonged half-life of oxycodone and its metabolites in patients with end-stage renal disease.
  • Oxycodone accumulation led to severe central nervous system and respiratory depression.

Implications:

  • Oxycodone should be prescribed with extreme caution in patients with chronic renal failure and those undergoing hemodialysis.
  • Healthcare providers must be vigilant for signs of opioid toxicity in renally impaired patients.
  • Alternative analgesics or dose adjustments may be necessary for effective and safe pain management in this population.